Parkinson's Disease Trial, Not Yet Recruiting NCT07074119 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07074119
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have had Parkinson's disease for more than 4 years
  • People between the ages of 46 and 83
  • People who experience motor fluctuations (changes in movement ability throughout the day), based on specific scores on a standard Parkinson's assessment scale
  • People who take levodopa (a common Parkinson's medication) at least 3 times per day
  • People whose neurologist has determined that their Parkinson's medication needs to be adjusted due to motor fluctuations
  • People whose Parkinson's symptoms, when at their worst, fall within a certain level of severity on a standard rating scale (Hoehn and Yahr stage 3 or below in the "off" state)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have not signed the required consent form
  • People who are unlikely or unable to complete a self-reported diary or wear the monitoring devices required by the trial
  • People with significant cognitive difficulties, based on a standard memory and thinking test score below 24
  • People who are currently receiving, or are planned to receive within the next 6 months, advanced Parkinson's treatments such as a medication pump (under the skin or digestive) or deep brain stimulation surgery
  • Women who are pregnant or breastfeeding
  • People who are currently living in a nursing home or residential care facility
  • People who are already taking part in another clinical trial or interventional study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 September 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in daily time spent in OFF state between baseline and 6 months visit, measured as the mean daily time in OFF state upon 3 days on self-reported diary.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov